Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Study completedNCT06690242
What this trial is testing

MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 115
Testing effectiveness (Phase 2)UnknownNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Large-scale testing (Phase 3)Study completedNCT01788046
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 515
Early research (Phase 1)Study completedNCT00792857
What this trial is testing

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT06747247
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 98
Large-scale testing (Phase 3)Study completedNCT01785849
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 508
Large-scale testing (Phase 3)Looking for participantsNCT03633708
What this trial is testing

Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 56
Testing effectiveness (Phase 2)Looking for participantsNCT06976177
What this trial is testing

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 310
Testing effectiveness (Phase 2)WithdrawnNCT01453634
What this trial is testing

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Who this might be right for
Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)
OPKO Health, Inc.
Large-scale testing (Phase 3)Study completedNCT01785875
What this trial is testing

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 891
Large-scale testing (Phase 3)Study completedNCT02102204
What this trial is testing

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 902